Health Consequences of Circadian Disruption in Humans and Animal Models - Progress in Molecular Biology and Translational Science - page 309

117. Vinogradova IA, Anisimov VN, Bukalev AV, Semenchenko AV, Zabezhinski MA.
Circadian disruption induced by light-at-night accelerates aging and promotes tumor-
igenesis in rats. Aging . 2009;1:855-865.
118. Dauchy RT, Blask DE, Sauer LA, Brainard GC, Krause JA. Dim light during darkness
stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism.
Cancer Lett . 1999;144:131-136.
119. Shah PN, Mhatre MC, Kothari LS. Effect of melatonin on mammary carcinogenesis in
intact and pinealectomized rats in varying photoperiods. Cancer Res .

1984;44:3403-3407.
120. Baydas G, Ercel E, Canatan H, Donder E, Akyol A. Effect of melatonin on oxidative
status of rat brain, liver and kidney tissues under constant light exposure. Cell Biochem
Funct . 2001;19:37-41.
121. Cruz A, Padillo FJ, Granados J, et al. Effect of melatonin on cholestatic oxidative stress
under constant light exposure. Cell Biochem Funct . 2003;21:377-380.
122. Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of
oxidative stress. A review. J Biomed Sci . 2000;7:444-458.
123. Nelson RJ, Blom JM. Photoperiodic effects on tumor development and immune func-
tion. J Biol Rhythms . 1994;9:233-249.
124. Bartsch H, Bartsch C. Effect of melatonin on experimental tumors under different pho-
toperiods and times of administration. J Neural Transm . 1981;52:269-279.
125. Gery S, Koeffler HP. The role of circadian regulation in cancer. Cold Spring Harb Symp
Quant Biol . 2007;72:459-464.
126. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important
role in tumor suppression and DNA damage response in vivo. Cell . 2002;111:41-50.
127. Lee CC. Tumor suppression by the mammalian Period genes. Cancer Causes Control .
2006;17:525-530.
128. Yang X, Wood PA, Ansell CM, et al. The circadian clock gene Per1 suppresses cancer
cell proliferation and tumor growth at specific times of day. Chronobiol Int .

2009;26:1323-1339.
129. Wood PA, Yang X, Taber A, et al. Period 2 mutation accelerates Apc Min/ þ tumorigen-
esis. Mol Cancer Res . 2008;6:1786-1793.
130. Gery S, Virk RK, Chumakov K, Yu A, Koeffler HP. The clock gene Per2 links the
circadian system to the estrogen receptor. Oncogene . 2007;26:7916-7920.
131. Xiang S, Coffelt SB, Mao L, et al. Period-2: a tumor suppressor gene in breast cancer.
J Circadian Rhythms . 2008;6:4.
132. Yang X, Wood PA, Oh EY, et al. Down regulation of circadian clock gene Period 2
accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer
Res Treat . 2009;117:423-431.
133. Gauger MA, Sancar A. Cryptochrome, circadian cycle, cell cycle checkpoints, and can-
cer. Cancer Res . 2005;65:6828-6834.
134. Kondratova AA, Dubrovsky YV, Antoch MP, Kondratov RV. Circadian clock pro-
teins control adaptation to novel environment and memory formation. Aging .
2010;2:285-297.
135. Khapre RV, Kondratova AA, Susova O, Kondratov RV. Circadian clock protein
BMAL1 regulates cellular senescence in vivo. Cell Cycle . 2011;10:4162-4169.
136. Ozturk N, Lee JH, Gaddameedhi S, Sancar A. Loss of cryptochrome reduces cancer risk
in p53 mutant mice. Proc Natl Acad Sci USA . 2009;106:2841-2846.
137. Hoffman AE, Yi CH, Zheng T, et al. CLOCK in breast tumorigenesis: genetic, epi-
genetic, and transcriptional profiling analyses. Cancer Res . 2010;70:1459-1468.
138. Zhou F, He X, Liu H, et al. Functional polymorphisms of circadian positive feedback
regulation genes and clinical outcome of Chinese patients with resected colorectal can-
cer. Cancer . 2012;118:937-946.